Krishna Ella

Bharat Biotech Partners With 2 Others For ‘Variant-Proof’ Covid Vaccine

NEW DELHI: India’s Bharat Biotech, Switzerland’s ExcellGene SA and University of Sydney have come together to manufacture a “variant-proof” Covid-19 vaccine. The SARS-CoV-2 vaccine candidate will be developed under the recently-approved consortium funding through the Coalition for Epidemic Preparedness Innovations (CEPI). Under this initiative, CEPI will provide funding up to USD 19.3 million for phase

Covaxin To Be Commercially Available In North America

  NEW DELHI: In a major development that will boost the world’s fight against the COVID-19 virus, Hyderabad-based Bharat Biotech on Thursday announced that its popular COVID vaccine Covaxin will now be commercially available in Mexico. The global leader in vaccine innovation, Bharat Biotech today announced that they have revised the agreement with US biotech